
Show
Approved
Life sciences, under the hood. Deep dives into the patent filings, regulatory gauntlets, and capital-risks that shape the business of biology.
5 episodes
- 18 Sep 2026Allergan: Botox, Rogue Scientists, and the Ultimate Beauty Franchise3h 36m
- 4 Aug 2026Blueprint Medicines: Chasing Gleevec to a $9B Allergy Drug2h 29m
- 14 May 2026Keytruda: How Merck's Pembrolizumab Became the Best-Selling Cancer Drug of All Time2h 7m
- 13 Mar 2026Episode #2: Geron2h 22m
- 30 Jan 2026Episode #1: Amylin Pharmaceuticals1h 46m